1. |
LAWICKI S, CZYGIER M, BEDKOWSKA E,et al.Comparative evaluation of plasma levels and diagnostic values of macrophagecolony stimulating factor in patients with breast cancer and benign tumors[J].Cancer Pol Arch Med Wewn,2008,118(9):464-469.
|
2. |
GROBLEWSKA M, MROCZKO B, WERESZCZYSKASIEMIATKOWSKA U,et al.Serum levels of granulocyte colonystimulating factor (G-CSF) and macrophage colonystimulating factor (M-CSF) in pancreatic cancer patients[J].Clin Chem Lab Med,2007,45(1):30-34.
|
3. |
KUROPKAT C, DUENNE A A, HERZ U,et al. Significant correlation of matrix metalloproteinase and macrophage colonystimulating factor serum concentrations in patients with head and neck cancer[J].Neoplasma,2004, 51(5):375-378.
|
4. |
IDE H, HATAKE K, TERADO Y,et al. Serum level of macrophage colonystimulating factor is increased in prostate cancer patients with bone metastasis[J].Hum Cell,2008,21(1):1-6.
|
5. |
TOY E P, AZODI M, FOLK N L,et al. Enhanced ovarian cancer tumorigenesis and metastasis by the macrophage colonystimulating factor[J].Neoplasia,2009,11(2):136-144.
|
6. |
MROCZKO B, GROBLEWSKA M, WERESZCZYSKASIEMIATKOWSKA U, et al. Serum macrophagecolony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis[J]. Clin Chim Acta,2007,380(1-2):208-212.
|
7. |
CALATAYUD S, WARNER T D, BREESE E J, et al. Relationship between endogenous colony stimulating factors and apoptosis in human colon cancer cells:role of cyclooxygenase inhibitors[J].Br J Pharmacol, 2001,134(6):1237-1244.
|
8. |
CALATAYUD S, WARNER T D, BREESE E J, et al. Modulation by colony stimulating factors of human epithelial colon cancer cell apoptosis[J].Cytokine,2002,20(4):163-167.
|